Genetic data consists of a wide range of marker types, including common, low-frequency, and rare variants. Multiple genetic markers and their interactions play central roles in the heritability of complex disease. In this study, we propose an algorithm that uses a stratified variable selection design by genetic architectures and interaction effects, achieved by a dataset-adaptive W-test.
INTRODUCTION
The risk of psychiatric disorders is largely attributed to genetic factors and their interactions with the environment (Smoller & Finn, 2003) .
The estimated heritability of bipolar disorder (BPD) is as high as 90%; however, few large main effect genes have been identified (Craddock & Sklar, 2013) . In recent years, exome sequencing studies identified a number of rare or de novo variants associated with bipolar disease risk (Goes et al., 2016 , Kataoka et al., 2016 . While these findings are very interesting and important, it is unclear how much they contribute to the prediction of complex disorders. The prediction challenge also lies in the diverse genetic marker compositions including common variants with minor allele frequencies (MAFs) greater than 5%, low-frequency variants (1% < MAF < 5%), and rare variants (MAF < 1%). Disease classification models typically do not distinguish these different variant types and use machine learning approaches to conduct variable selection and phenotype prediction (Touw et al., 2013) . The distinct nature of these genetic markers requires specialized statistical models to evaluate their risk effect. Therefore, in this study, we developed a stratified polygenic risk model: from simple to complex, the model is gradually built based on the effect of common and low-frequency variants and their respective epistasis. When the sample size is sufficiently large, the model may include rare variants. Variable selection is conducted using the W-test, which estimates null probability distributions of each stratum. The polygenic risk sets from all strata are finally integrated to form a unified classification rule through boosting. The method was applied to the Critical Assessment of Genome Interpretation 4 (CAGI 4) bipolar challenge, which contains exome sequencing data for 500 subjects with the objective of predicting an independent test set. Context is challenging for complex disease predictions, as rare variation association tests require a large sample size to have enough power; furthermore, rare mutations may not reappear in another sampling group of modest size. Therefore, we focused on common-to lowfrequency variables and their epistasis effect in the challenge. Using the proposed model, the prediction accuracy for the independent test set was 60%, mainly because of common variant polygenic epistasis.
METHOD

Data set and quality control
The data set included whole-exome sequencing data consisting of 500 samples and 501,253 single-nucleotide polymorphisms (SNPs), sequenced using the Illumina HiSeq 2000 platform (San Diego, CA).
Variants with more than 5% missing or Hardy-Weinberg equilibrium test P value < 10 −6 were filtered first. Principle component analysis based on the remaining SNPs identified a cluster of three outlier subjects, which were excluded from further analysis (Price et al., 2006) .
The remaining data consisted of 226 BPD subjects and 221 healthy controls. From the total of 497 subjects, 50 individuals were randomly drawn as the independent test set, whereas the remaining 447 subjects were used as the training set. Missing SNP data were imputed using SHAPEIT2 (Delaneau, Zagury, & Marchini, 2013) . SNPs with MAF above 1% were analyzed. The total number of low to common frequency SNPs evaluated was 75,288, among which 21,339 SNPs had MAFs between 1% and 5% and 53,949 SNPs had MAFs > 5%. Feature selection was performed without using SNP location information. The final selected SNPs were mapped to genes using the UCSC Genome Browser on Human within a 10-kb genome distance (Kent et al., 2002) .
Stratified variable selection via W-test
We used the W-test to select important variables and construct epistasis sets . The W-test measures the distributional differences between cases and controls in a contingency table and follows a chi-square distribution with data-set-adaptive degrees of freedom. This feature makes the test robust to small sample sizes and complex genetic architectures. The test statistic takes the following form:
where k is the number of categories formed by a marker set. For a single SNP, k = 3 and for an SNP pair, k = 9.p 1i is the proportion of subjects in cell i in cases, andp 0i is the proportion of subjects in cell i among total controls. SE i is the standard error of the log odds ratio of cell i, in which n 1i and n 0i are the number of cases and controls in the i th cell; N 1 and N 0 are the total number of cases and controls, respectively. The statistic follows a chi-squared distribution of f degrees of freedom. The scalar
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h and degrees of freedom f were obtained by estimating the covariance matrix from bootstrapped samples under the null hypothesis. The W-test was performed using the wtest package in R .
Genetic risk variables were selected in a stratified manner by evaluating the: (1) main effect of common variants, (2) epistasis effect among common variants, (3) main effects of low-frequency variants, and (4) epistasis effect among low-frequency variants. The W-test adaptively estimates the probability distribution according to the genetic architecture of each stratum and provides an accurate evaluation of association effects. The procedure is illustrated in Diagram 1.
Classification algorithm
The top genetic markers were candidates for the adaptive-boosting (ada-boost) algorithm (Schapire, 1999) . Each SNP or SNP pair forms a classifier through logistic regression. The ada-boost recursively selects the next best classifier from the remaining classifiers list, and each time reweights all samples based on the prediction error rate in the training set, with samples that are more difficult to classify given heavier weights. The algorithm is most suitable for aggregating multiple modest effect classifiers to form a stronger rule. Before submitting the classifiers to boosting, a filtering method is applied to remove the dependency among the pairs: first, all pairwise interactions were evaluated among SNPs with main effect P values < 0.1; second, these pairs were evaluated using the W-test and ranked by P value in an ascending order; third, an SNP pair will be removed if it contains an overlapping SNP in a set . This screening method was used for two reasons: (1) when an SNP has a very strong main effect, it can couple with a large number of SNPs to form significant pairs, most of which are redundant and do not help the prediction. Filtering can remove most of these main effect-driven pairs and allows new epistasis that reveals additional information for classification; (2) filtering 
RESULTS
Classification results
For common SNPs, 21 variants with main effect P values < 1 × 10 −5 were selected. The classification error rate was 31% for the training set and 48.0% for the independent test set (Supp. Fig. S1 ). For common variant epistasis, variants with main effect P values smaller than 0.1 were used to calculate pair-wise interactions. The number of SNPs with main effect P values < 0.1 was 5,521. The Bonferroni-corrected significance level at a nominal alpha 0.05 was 3.28 × 10 −9 . The top 24 pairs with P values smaller than 1 × 10 −5 were used in the classification algorithm. The final error rate for the training set was 24.1%
and for the independent test set was 40.0%. No prior biological knowledge or clinical characteristics has been used, and the classification was purely based on SNP data. Figure 1 shows the adaptively improved boosting error; the algorithm updates voting rule in each iteration and decreased the overall error rates as more classifiers are added. The error of the test set decreased with fluctuation and stabilized at 40.0% for the final six iterations, indicating that the classifier was not overtrained in the training set (Fig. 1) .
For low-frequency variants, the same procedure was used to select main effect SNPs and epistasis pairs. However, when these variables were added to the previous common variants sets, the test set error rates increased to 46%. This demonstrates that the low-frequency variant did not improve prediction of the disease phenotype, although the results may be limited because of the small sample size.
Top SNP pairs are biologically relevant
The top 24 common pairs consisted of 48 unique SNPs, 45 of which were located in protein coding genes; pairs located in known psychiatric genes are listed in Table 1 (the full table can F I G U R E 2 Epistasis network in BPD common variants (Fig. 2) . Because none of the SNPs in GAS7 were marginally significant, the epistasis did not result from a large main effect. GAS7 is also known as MLL and plays a putative role in brain development by regulating neuronal cell morphology (Chao, Chang, & Lu, 2005 , Gotoh, Hidaka, Hirose, & Uchida, 2013 , and is known to be related to Alzheimer's disease (Hidaka et al., 2012) . Another significant epistasis pair was found between CPNE5 and CRLF1. Both genes play roles in neuronal disorder. CPNE5 is a calcium-dependent membrane-binding protein and was reported to be associated with alcohol dependence and obesity (Wang, Zuo, Pan, Xie, & Luo, 2015) ; CRLF1 encodes a protein complex that acts on cells expressing ciliary neurotrophic factor receptors and promotes the survival of neuronal cells (Herholz et al., 2011; NCBI, n.d.) .
SDF4 also encodes proteins containing calcium-binding motifs. The top genes identified are consistent with the findings that the etiology of BPD involves calcium-channel.
DISCUSSION
In this study, an algorithm for stratified variable selection by genetic architecture and classification was developed. We used main and epistasis effects in common variants and low-frequency variants to perform BPD phenotype prediction. Our results showed that the classification algorithm utilizing common variants interactions reached 60% accuracy in disease classification.
To design a risk prediction model, we first conducted stratification, followed by consolidation. Genetic marker selection was stratified by the genetic architectures of common and low frequencies, and then by main and interaction effects. The advantage of stratification is that it improves the inference of variable selection. Therefore, the statistical method that is most suitable for that stratum's genetic architecture can be applied. For the W-test, a different set of h and f parameters for the data-adaptive probability distribution was estimated for each stratum. In the prediction step, all risk effects were combined through the boosting algorithm to produce a final vote. The stratification effect is clear: when only main effect common variants were included in the model, the independent test error rate was 48% (Supp. (2016) demonstrated the necessity of understanding the relative contribution of common, low-frequency, and rare variants toward absolute risk estimation for genetic disease diagnosis. Our findings are also consistent with the current understanding of BPD, a highly complex disease triggered by polygenic effects and the interplay of environmental factors.
In the feature selection part, the W-test was used to test the main effects and epistasis effects. The method has three distinct characteristics that differentiate it from other statistical methods. First, the test is data set adaptive; it contains a degree of freedom parameter and scalar that are adjusted according to the data structure of each dataset, and therefore produces data-set-adaptive null distributions that allow for more accurate P value calculation. Second, the W-test is model-free; it is constructed by directly testing the distributional differences between the cases and control groups. Thus, the method is not restricted by assumptions such as linearity and may capture effects arising from different types of associations, linear or nonlinear.
Third, the W-test has a closed statistical form and calculates a P value from a probability distribution. These properties make the W-test a practical and interpretable method applicable for large genetic dataset analysis.
One of the limitations of the study is the sample size, which prevented us from fully determining the effect of low-frequency and rare variants effect in disease classification. Clinical and environmental variables were also unavailable and thus could not be incorporated into the algorithm. However, using the CAGI project bipolar challenge dataset, we demonstrated the important contribution of common variants to complex disorder risk prediction, with the most substantial improvement of accuracy made by including epistasis among the SNPs.
This CAGI project data set was generated from a single batch, and thus there was no systematic difference in the training and testing set. In real-life scenarios, when applying the prediction algorithm to a distant data set, the classification model should be calibrated for the test set to ensure unbiased estimation. The identified polygenic markers used in the final prediction model must also be validated in future studies.
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